Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Manfroni

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Future Medicinal Chemistry|June 1, 2021
Targeting miRNA dysregulation with small molecules: the case of enoxacinTommaso Felicetti, Giuseppe Manfroni
Future Medicinal Chemistry|March 31, 2023
Truth and lies about the use of old drugs against COVID-19: have we learned the lesson?Carmine Iorio, Giuseppe Manfroni
Journal of Medicinal Chemistry|July 17, 2020
Modulating microRNA Processing: Enoxacin, the Progenitor of a New Class of DrugsTommaso Felicetti, Violetta Cecchetti, Giuseppe Manfroni
Current Medicinal Chemistry|June 15, 2022
Broad-Spectrum Anti-Flavivirus Activity and Chemistry of Compounds Containing Sulfur and Oxygen ChalcogensMaria Sole Burali, Violetta Cecchetti, Giuseppe Manfroni
Chemmedchem|September 22, 2020
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of ViewTommaso Felicetti, Giuseppe Manfroni, Violetta Cecchetti, et al.
Chemmedchem|December 7, 2017
A Comprehensive Structural Overview of p38α Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site BindersAndrea Astolfi, Giuseppe Manfroni, Violetta Cecchetti, et al.
Journal of Medicinal Chemistry|August 5, 2015
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug CandidatesRolando Cannalire, Maria Letizia Barreca, Giuseppe Manfroni, et al.
European Journal of Medicinal Chemistry|September 13, 2025
A medicinal chemistry overview of direct-acting antivirals approved in 2013-2024 by US FDAMaria Giulia Nizi, Serena Massari, Oriana Tabarrini, et al.
Future Medicinal Chemistry|June 29, 2011
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and developmentMaria Letizia Barreca, Nunzio Iraci, Giuseppe Manfroni, et al.
Journal of Medicinal Chemistry|July 6, 2024
Recent Progress toward the Discovery of Small Molecules as Novel Anti-Respiratory Syncytial Virus AgentsTommaso Felicetti, Chiara Sarnari, Roberta Gaito, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Future Medicinal Chemistry|June 1, 2021
Targeting miRNA dysregulation with small molecules: the case of enoxacinTommaso Felicetti, Giuseppe Manfroni
Future Medicinal Chemistry|March 31, 2023
Truth and lies about the use of old drugs against COVID-19: have we learned the lesson?Carmine Iorio, Giuseppe Manfroni
Journal of Medicinal Chemistry|July 17, 2020
Modulating microRNA Processing: Enoxacin, the Progenitor of a New Class of DrugsTommaso Felicetti, Violetta Cecchetti, Giuseppe Manfroni
Current Medicinal Chemistry|June 15, 2022
Broad-Spectrum Anti-Flavivirus Activity and Chemistry of Compounds Containing Sulfur and Oxygen ChalcogensMaria Sole Burali, Violetta Cecchetti, Giuseppe Manfroni
Chemmedchem|September 22, 2020
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of ViewTommaso Felicetti, Giuseppe Manfroni, Violetta Cecchetti, et al.
Chemmedchem|December 7, 2017
A Comprehensive Structural Overview of p38α Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site BindersAndrea Astolfi, Giuseppe Manfroni, Violetta Cecchetti, et al.
Journal of Medicinal Chemistry|August 5, 2015
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug CandidatesRolando Cannalire, Maria Letizia Barreca, Giuseppe Manfroni, et al.
European Journal of Medicinal Chemistry|September 13, 2025
A medicinal chemistry overview of direct-acting antivirals approved in 2013-2024 by US FDAMaria Giulia Nizi, Serena Massari, Oriana Tabarrini, et al.
Future Medicinal Chemistry|June 29, 2011
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and developmentMaria Letizia Barreca, Nunzio Iraci, Giuseppe Manfroni, et al.
Journal of Medicinal Chemistry|July 6, 2024
Recent Progress toward the Discovery of Small Molecules as Novel Anti-Respiratory Syncytial Virus AgentsTommaso Felicetti, Chiara Sarnari, Roberta Gaito, et al.
Pageof 9